• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSB

MESOBLAST LIMITED - Announcements

0.00% ! $2.29
Market Cap $2.931B  !

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Announcements



MSB Appendix 4C - quarterly30/10/15 download Created with Sketch. 437.17KB
MSB Suspension from Official QuotationPRICE SENSITIVE30/10/15 download Created with Sketch. 538.38KB
MSB Key US Patent Granted For Heart, Stroke, Vascular DiseasesPRICE SENSITIVE28/10/15 download Created with Sketch. 65.41KB
MSB Results of Meeting22/10/15 download Created with Sketch. 189.67KB
MSB CEO Presentation To 2015 Annual General Meeting22/10/15 download Created with Sketch. 1.37MB
MSB Chairman's Address to Shareholders22/10/15 download Created with Sketch. 86.44KB
MSB Celgene And Mesoblast Extend AgreementPRICE SENSITIVE16/10/15 download Created with Sketch. 68.19KB
MSB MSB Cell Therapy Shows Greatest Effect In Advanced CHFPRICE SENSITIVE30/09/15 download Created with Sketch. 100.18KB
MSB Annual Report to shareholders21/09/15 download Created with Sketch. 3.71MB
MSB Notice of Annual General Meeting/Proxy Form21/09/15 download Created with Sketch. 295.18KB
MSB Appendix 4G And Corporate Governance Statement21/09/15 download Created with Sketch. 335.43KB
MSB Full Japanese Approval For MSC ProductPRICE SENSITIVE18/09/15 download Created with Sketch. 102.13KB
MSB Appendix 3B11/09/15 download Created with Sketch. 279.18KB
MSB MSB Partner JCR Receives Recommendation For Japan ApprovalPRICE SENSITIVE04/09/15 download Created with Sketch. 89.12KB
MSB MSB 2015 Annual Financial Results Presentation17/08/15 download Created with Sketch. 1.18MB
MSB 2015 Financial Year Results And Update On P3 CHF Trial17/08/15 download Created with Sketch. 113.52KB
MSB Preliminary Final ReportPRICE SENSITIVE17/08/15 download Created with Sketch. 1.46MB
MSB Appendix 4C - quarterlyPRICE SENSITIVE31/07/15 download Created with Sketch. 257.97KB
MSB Type 2 Diabetes Trial Results Published In Diabetes CarePRICE SENSITIVE23/07/15 download Created with Sketch. 114.93KB
MSB CHF Phase 2 Trial Results Published In Circulation ResearchPRICE SENSITIVE15/07/15 download Created with Sketch. 313.33KB
MSB Change of Director's Interest Notice13/07/15 download Created with Sketch. 79.55KB
MSB Positive Diabetic Nephropathy Trial ResultsPRICE SENSITIVE09/06/15 download Created with Sketch. 128.34KB
MSB Mesoblast Receives $5.8m From Aus Govt For R&DPRICE SENSITIVE05/06/15 download Created with Sketch. 87.26KB
MSB Appendix 3B and ASIC Form 48404/06/15 download Created with Sketch. 365.74KB
MSB Diabetic Nephropathy Results To Be Presented At ADA MeetingPRICE SENSITIVE18/05/15 download Created with Sketch. 91.84KB
MSB Reversed Arterial Dysfunction And Inflammation in RA ModelPRICE SENSITIVE12/05/15 download Created with Sketch. 112.44KB
MSB Employee share scheme buy-back completion - Appendix 3E & 3F05/05/15 download Created with Sketch. 244.03KB
MSB Employee share scheme buy-back - Appendix 3C01/05/15 download Created with Sketch. 181.51KB
MSB Appendix 3B17/04/15 download Created with Sketch. 285.38KB
MSB Appendix 4C - quarterlyPRICE SENSITIVE17/04/15 download Created with Sketch. 258.13KB
MSB Becoming a substantial holder from TOP17/04/15 download Created with Sketch. 164.03KB
MSB Celgene And Mesoblast Enter Into AgreementPRICE SENSITIVE13/04/15 download Created with Sketch. 82.42KB
MSB Positive EMA Meeting For Phase 3 Disc Repair ProgramPRICE SENSITIVE08/04/15 download Created with Sketch. 71.35KB
MSB Key Patent Allowed In Japan For Heart Diseases, StrokePRICE SENSITIVE27/03/15 download Created with Sketch. 73.02KB
MSB Change in substantial holding25/03/15 download Created with Sketch. 111.46KB
MSB Appendix 3B20/03/15 download Created with Sketch. 283.54KB
MSB Fast Track Access To Potential Japan Investment IncentivesPRICE SENSITIVE19/03/15 download Created with Sketch. 84.21KB
MSB Results Show Improved Survival in Children with GVHDPRICE SENSITIVE16/02/15 download Created with Sketch. 345.52KB
MSB Mesoblast Reports Half-Year Results12/02/15 download Created with Sketch. 114.12KB
MSB Mesoblast Half-Year Results Presentation12/02/15 download Created with Sketch. 1.33MB
MSB Half Yearly Report and AccountsPRICE SENSITIVE12/02/15 download Created with Sketch. 499.71KB
MSB Key US patent granted for treatment of degenerated discsPRICE SENSITIVE10/02/15 download Created with Sketch. 67.56KB
MSB Appendix 4C - quarterlyPRICE SENSITIVE30/01/15 download Created with Sketch. 259.08KB
MSB P3 trial initiated, positive 24 mth P2 results in back painPRICE SENSITIVE15/01/15 download Created with Sketch. 99.1KB
MSB Appendix 3B31/12/14 download Created with Sketch. 275.36KB
MSB Key Mesoblast Patent Claims Upheld in EuropePRICE SENSITIVE16/12/14 download Created with Sketch. 84.5KB
MSB Release of Shares from Voluntary Escrow04/12/14 download Created with Sketch. 83.83KB
MSB Appendix 3B26/11/14 download Created with Sketch. 281.36KB
MSB Change of Director's Interest Notice26/11/14 download Created with Sketch. 77.86KB
MSB Results of Meeting25/11/14 download Created with Sketch. 174.86KB
MSB CEO Presentation to 2014 Annual General Meeting25/11/14 download Created with Sketch. 1.41MB
MSB Chairman's Address to Shareholders25/11/14 download Created with Sketch. 290.85KB
MSB Japanese Law Expediting Cell Therapy Approvals Takes Effect25/11/14 download Created with Sketch. 295.99KB
MSB Chronic Low Back Pain Results Presented at NASSPRICE SENSITIVE13/11/14 download Created with Sketch. 1.11MB
MSB Appendix 4C - quarterlyPRICE SENSITIVE31/10/14 download Created with Sketch. 253.61KB
MSB Release of Shares from Voluntary Escrow29/10/14 download Created with Sketch. 155.6KB
MSB Change of Director's Interest Notice29/10/14 download Created with Sketch. 80.28KB
MSB Notice of Annual General Meeting/Proxy Form23/10/14 download Created with Sketch. 722.89KB
MSB Annual Report to shareholders23/10/14 download Created with Sketch. 2.9MB
MSB MSB PARTNER JCR FILES FOR PRODUCT APPROVALPRICE SENSITIVE01/10/14 download Created with Sketch. 286.25KB
MSB Appendix 3B26/09/14 download Created with Sketch. 274.85KB
MSB Company Secretary Appointment/Resignation29/08/14 download Created with Sketch. 66.38KB
MSB MSB 2014 Annual Financial Results Presentation26/08/14 download Created with Sketch. 1.79MB
MSB MSB Unveils Path to Bring its Key Products to MarketPRICE SENSITIVE26/08/14 download Created with Sketch. 423.24KB
MSB Preliminary Final ReportPRICE SENSITIVE26/08/14 download Created with Sketch. 1.53MB
MSB Pharmaceutical Executive Appointed as Mesoblast CFO25/08/14 download Created with Sketch. 242.36KB
MSB Change of Director's Interest Notice22/08/14 download Created with Sketch. 75.88KB
MSB Appendix 3B22/08/14 download Created with Sketch. 275.33KB
MSB MSB & NIH Agree 120 Patient Trial In End-Stage Heart FailurePRICE SENSITIVE07/08/14 download Created with Sketch. 90.85KB
MSB Appendix 4C - quarterlyPRICE SENSITIVE31/07/14 download Created with Sketch. 255.04KB
MSB Appendix 3B15/07/14 download Created with Sketch. 255.98KB
MSB Circulation Publishes Improved Outcomes with Mesoblast CellsPRICE SENSITIVE25/06/14 download Created with Sketch. 339.78KB
MSB Appendix 3B24/06/14 download Created with Sketch. 303.76KB
MSB Details of Company Address20/06/14 download Created with Sketch. 149.87KB
MSB Type 2 Diabetes Results Presented by Study Investigators19/06/14 download Created with Sketch. 110.38KB
MSB Mesoblast Receives $5.05m for Stem Cell Pipeline DevelopmentPRICE SENSITIVE16/06/14 download Created with Sketch. 61.45KB
MSBResponse to ASX Price QueryPRICE SENSITIVE06/06/14 download Created with Sketch. 115.33KB
MSBMSB Accelerates Plans for Commercial Manufacturing OperationPRICE SENSITIVE28/05/14 download Created with Sketch. 248.58KB
MSBAppendix 3B02/05/14 download Created with Sketch. 371.89KB
MSBAppendix 4C - quarterlyPRICE SENSITIVE30/04/14 download Created with Sketch. 187.82KB
MSBAppendix 3B30/04/14 download Created with Sketch. 218.64KB
MSBMESOBLAST PROVIDES UPDATE ON CLINICAL PROGRAMS OF PROCHYMALPRICE SENSITIVE29/04/14 download Created with Sketch. 153.9KB
MSBResponse to ASX price queryPRICE SENSITIVE08/04/14 download Created with Sketch. 227.71KB
MSBKeynote Presentation to Alliance for Regenerative Medicine27/03/14 download Created with Sketch. 919.3KB
MSBInitial Director's Interest Notice12/03/14 download Created with Sketch. 65.99KB
MSBKey Pharmaceutical Executive Joins Mesoblast11/03/14 download Created with Sketch. 84.54KB
MSB2014 Half-Year Financial Results & Corporate Strategy26/02/14 download Created with Sketch. 1.76MB
MSBMesoblast Reports Strong Half-Year Financial Results26/02/14 download Created with Sketch. 89.23KB
MSBHalf Yearly Report and AccountsPRICE SENSITIVE26/02/14 download Created with Sketch. 360KB
MSBKey European Patent Granted for Mesoblast's MPCsPRICE SENSITIVE20/02/14 download Created with Sketch. 102.94KB
MSBBoardroom Radio Interview with Mesoblast Chief Executive03/02/14 download Created with Sketch. 313.7KB
MSBChange in substantial holding03/02/14 download Created with Sketch. 44.91KB
MSBAppendix 4C - quarterlyPRICE SENSITIVE31/01/14 download Created with Sketch. 245.07KB
MSBPositive Disc Repair Results Using Mesoblast Stem CellsPRICE SENSITIVE30/01/14 download Created with Sketch. 345.69KB
MSBBecoming a substantial holder09/01/14 download Created with Sketch. 115.7KB
MSBAppendix 3B20/12/13 download Created with Sketch. 246.46KB
MSBMesoblast Reports Positive Type 2 Diabetes Trial ResultsPRICE SENSITIVE04/12/13 download Created with Sketch. 335.25KB
MSBNew Japanese Regenerative Medicine LegislationPRICE SENSITIVE25/11/13 download Created with Sketch. 282.6KB
MSBScrip Award to Mesoblast for 2013 Financing Deal of the Year22/11/13 download Created with Sketch. 306.48KB
MSBMPCs Strengthen Cardiac Function in End-Stage Heart FailurePRICE SENSITIVE19/11/13 download Created with Sketch. 253.28KB
MSB Appendix 4C - quarterly
30/10/15 download Created with Sketch. 437.17KB
MSB Suspension from Official Quotation
30/10/15PRICE SENSITIVE download Created with Sketch. 538.38KB
MSB Key US Patent Granted For Heart, Stroke, Vascular Diseases
28/10/15PRICE SENSITIVE download Created with Sketch. 65.41KB
MSB Results of Meeting
22/10/15 download Created with Sketch. 189.67KB
MSB CEO Presentation To 2015 Annual General Meeting
22/10/15 download Created with Sketch. 1.37MB
MSB Chairman's Address to Shareholders
22/10/15 download Created with Sketch. 86.44KB
MSB Celgene And Mesoblast Extend Agreement
16/10/15PRICE SENSITIVE download Created with Sketch. 68.19KB
MSB MSB Cell Therapy Shows Greatest Effect In Advanced CHF
30/09/15PRICE SENSITIVE download Created with Sketch. 100.18KB
MSB Annual Report to shareholders
21/09/15 download Created with Sketch. 3.71MB
MSB Notice of Annual General Meeting/Proxy Form
21/09/15 download Created with Sketch. 295.18KB
MSB Appendix 4G And Corporate Governance Statement
21/09/15 download Created with Sketch. 335.43KB
MSB Full Japanese Approval For MSC Product
18/09/15PRICE SENSITIVE download Created with Sketch. 102.13KB
MSB Appendix 3B
11/09/15 download Created with Sketch. 279.18KB
MSB MSB Partner JCR Receives Recommendation For Japan Approval
04/09/15PRICE SENSITIVE download Created with Sketch. 89.12KB
MSB MSB 2015 Annual Financial Results Presentation
17/08/15 download Created with Sketch. 1.18MB
MSB 2015 Financial Year Results And Update On P3 CHF Trial
17/08/15 download Created with Sketch. 113.52KB
MSB Preliminary Final Report
17/08/15PRICE SENSITIVE download Created with Sketch. 1.46MB
MSB Appendix 4C - quarterly
31/07/15PRICE SENSITIVE download Created with Sketch. 257.97KB
MSB Type 2 Diabetes Trial Results Published In Diabetes Care
23/07/15PRICE SENSITIVE download Created with Sketch. 114.93KB
MSB CHF Phase 2 Trial Results Published In Circulation Research
15/07/15PRICE SENSITIVE download Created with Sketch. 313.33KB
MSB Change of Director's Interest Notice
13/07/15 download Created with Sketch. 79.55KB
MSB Positive Diabetic Nephropathy Trial Results
09/06/15PRICE SENSITIVE download Created with Sketch. 128.34KB
MSB Mesoblast Receives $5.8m From Aus Govt For R&D
05/06/15PRICE SENSITIVE download Created with Sketch. 87.26KB
MSB Appendix 3B and ASIC Form 484
04/06/15 download Created with Sketch. 365.74KB
MSB Diabetic Nephropathy Results To Be Presented At ADA Meeting
18/05/15PRICE SENSITIVE download Created with Sketch. 91.84KB
MSB Reversed Arterial Dysfunction And Inflammation in RA Model
12/05/15PRICE SENSITIVE download Created with Sketch. 112.44KB
MSB Employee share scheme buy-back completion - Appendix 3E & 3F
05/05/15 download Created with Sketch. 244.03KB
MSB Employee share scheme buy-back - Appendix 3C
01/05/15 download Created with Sketch. 181.51KB
MSB Appendix 3B
17/04/15 download Created with Sketch. 285.38KB
MSB Appendix 4C - quarterly
17/04/15PRICE SENSITIVE download Created with Sketch. 258.13KB
MSB Becoming a substantial holder from TOP
17/04/15 download Created with Sketch. 164.03KB
MSB Celgene And Mesoblast Enter Into Agreement
13/04/15PRICE SENSITIVE download Created with Sketch. 82.42KB
MSB Positive EMA Meeting For Phase 3 Disc Repair Program
08/04/15PRICE SENSITIVE download Created with Sketch. 71.35KB
MSB Key Patent Allowed In Japan For Heart Diseases, Stroke
27/03/15PRICE SENSITIVE download Created with Sketch. 73.02KB
MSB Change in substantial holding
25/03/15 download Created with Sketch. 111.46KB
MSB Appendix 3B
20/03/15 download Created with Sketch. 283.54KB
MSB Fast Track Access To Potential Japan Investment Incentives
19/03/15PRICE SENSITIVE download Created with Sketch. 84.21KB
MSB Results Show Improved Survival in Children with GVHD
16/02/15PRICE SENSITIVE download Created with Sketch. 345.52KB
MSB Mesoblast Reports Half-Year Results
12/02/15 download Created with Sketch. 114.12KB
MSB Mesoblast Half-Year Results Presentation
12/02/15 download Created with Sketch. 1.33MB
MSB Half Yearly Report and Accounts
12/02/15PRICE SENSITIVE download Created with Sketch. 499.71KB
MSB Key US patent granted for treatment of degenerated discs
10/02/15PRICE SENSITIVE download Created with Sketch. 67.56KB
MSB Appendix 4C - quarterly
30/01/15PRICE SENSITIVE download Created with Sketch. 259.08KB
MSB P3 trial initiated, positive 24 mth P2 results in back pain
15/01/15PRICE SENSITIVE download Created with Sketch. 99.1KB
MSB Appendix 3B
31/12/14 download Created with Sketch. 275.36KB
MSB Key Mesoblast Patent Claims Upheld in Europe
16/12/14PRICE SENSITIVE download Created with Sketch. 84.5KB
MSB Release of Shares from Voluntary Escrow
04/12/14 download Created with Sketch. 83.83KB
MSB Appendix 3B
26/11/14 download Created with Sketch. 281.36KB
MSB Change of Director's Interest Notice
26/11/14 download Created with Sketch. 77.86KB
MSB Results of Meeting
25/11/14 download Created with Sketch. 174.86KB
MSB CEO Presentation to 2014 Annual General Meeting
25/11/14 download Created with Sketch. 1.41MB
MSB Chairman's Address to Shareholders
25/11/14 download Created with Sketch. 290.85KB
MSB Japanese Law Expediting Cell Therapy Approvals Takes Effect
25/11/14 download Created with Sketch. 295.99KB
MSB Chronic Low Back Pain Results Presented at NASS
13/11/14PRICE SENSITIVE download Created with Sketch. 1.11MB
MSB Appendix 4C - quarterly
31/10/14PRICE SENSITIVE download Created with Sketch. 253.61KB
MSB Release of Shares from Voluntary Escrow
29/10/14 download Created with Sketch. 155.6KB
MSB Change of Director's Interest Notice
29/10/14 download Created with Sketch. 80.28KB
MSB Notice of Annual General Meeting/Proxy Form
23/10/14 download Created with Sketch. 722.89KB
MSB Annual Report to shareholders
23/10/14 download Created with Sketch. 2.9MB
MSB MSB PARTNER JCR FILES FOR PRODUCT APPROVAL
01/10/14PRICE SENSITIVE download Created with Sketch. 286.25KB
MSB Appendix 3B
26/09/14 download Created with Sketch. 274.85KB
MSB Company Secretary Appointment/Resignation
29/08/14 download Created with Sketch. 66.38KB
MSB MSB 2014 Annual Financial Results Presentation
26/08/14 download Created with Sketch. 1.79MB
MSB MSB Unveils Path to Bring its Key Products to Market
26/08/14PRICE SENSITIVE download Created with Sketch. 423.24KB
MSB Preliminary Final Report
26/08/14PRICE SENSITIVE download Created with Sketch. 1.53MB
MSB Pharmaceutical Executive Appointed as Mesoblast CFO
25/08/14 download Created with Sketch. 242.36KB
MSB Change of Director's Interest Notice
22/08/14 download Created with Sketch. 75.88KB
MSB Appendix 3B
22/08/14 download Created with Sketch. 275.33KB
MSB MSB & NIH Agree 120 Patient Trial In End-Stage Heart Failure
07/08/14PRICE SENSITIVE download Created with Sketch. 90.85KB
MSB Appendix 4C - quarterly
31/07/14PRICE SENSITIVE download Created with Sketch. 255.04KB
MSB Appendix 3B
15/07/14 download Created with Sketch. 255.98KB
MSB Circulation Publishes Improved Outcomes with Mesoblast Cells
25/06/14PRICE SENSITIVE download Created with Sketch. 339.78KB
MSB Appendix 3B
24/06/14 download Created with Sketch. 303.76KB
MSB Details of Company Address
20/06/14 download Created with Sketch. 149.87KB
MSB Type 2 Diabetes Results Presented by Study Investigators
19/06/14 download Created with Sketch. 110.38KB
MSB Mesoblast Receives $5.05m for Stem Cell Pipeline Development
16/06/14PRICE SENSITIVE download Created with Sketch. 61.45KB
MSBResponse to ASX Price Query
06/06/14PRICE SENSITIVE download Created with Sketch. 115.33KB
MSBMSB Accelerates Plans for Commercial Manufacturing Operation
28/05/14PRICE SENSITIVE download Created with Sketch. 248.58KB
MSBAppendix 3B
02/05/14 download Created with Sketch. 371.89KB
MSBAppendix 4C - quarterly
30/04/14PRICE SENSITIVE download Created with Sketch. 187.82KB
MSBAppendix 3B
30/04/14 download Created with Sketch. 218.64KB
MSBMESOBLAST PROVIDES UPDATE ON CLINICAL PROGRAMS OF PROCHYMAL
29/04/14PRICE SENSITIVE download Created with Sketch. 153.9KB
MSBResponse to ASX price query
08/04/14PRICE SENSITIVE download Created with Sketch. 227.71KB
MSBKeynote Presentation to Alliance for Regenerative Medicine
27/03/14 download Created with Sketch. 919.3KB
MSBInitial Director's Interest Notice
12/03/14 download Created with Sketch. 65.99KB
MSBKey Pharmaceutical Executive Joins Mesoblast
11/03/14 download Created with Sketch. 84.54KB
MSB2014 Half-Year Financial Results & Corporate Strategy
26/02/14 download Created with Sketch. 1.76MB
MSBMesoblast Reports Strong Half-Year Financial Results
26/02/14 download Created with Sketch. 89.23KB
MSBHalf Yearly Report and Accounts
26/02/14PRICE SENSITIVE download Created with Sketch. 360KB
MSBKey European Patent Granted for Mesoblast's MPCs
20/02/14PRICE SENSITIVE download Created with Sketch. 102.94KB
MSBBoardroom Radio Interview with Mesoblast Chief Executive
03/02/14 download Created with Sketch. 313.7KB
MSBChange in substantial holding
03/02/14 download Created with Sketch. 44.91KB
MSBAppendix 4C - quarterly
31/01/14PRICE SENSITIVE download Created with Sketch. 245.07KB
MSBPositive Disc Repair Results Using Mesoblast Stem Cells
30/01/14PRICE SENSITIVE download Created with Sketch. 345.69KB
MSBBecoming a substantial holder
09/01/14 download Created with Sketch. 115.7KB
MSBAppendix 3B
20/12/13 download Created with Sketch. 246.46KB
MSBMesoblast Reports Positive Type 2 Diabetes Trial Results
04/12/13PRICE SENSITIVE download Created with Sketch. 335.25KB
MSBNew Japanese Regenerative Medicine Legislation
25/11/13PRICE SENSITIVE download Created with Sketch. 282.6KB
MSBScrip Award to Mesoblast for 2013 Financing Deal of the Year
22/11/13 download Created with Sketch. 306.48KB
MSBMPCs Strengthen Cardiac Function in End-Stage Heart Failure
19/11/13PRICE SENSITIVE download Created with Sketch. 253.28KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.29
Change
0.000(0.00%)
Mkt cap ! $2.931B
Open High Low Value Volume
$2.26 $2.31 $2.25 $4.493M 1.965M

Buyers (Bids)

No. Vol. Price($)
1 13044 $2.28
 

Sellers (Offers)

Price($) Vol. No.
$2.29 4885 3
View Market Depth
Last trade - 16.14pm 12/08/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.